Tauns Laboratories (TSE:197A) Accounts Payable: 円1,069 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
15 GF Score
Price 円468.00
! 6 Warning Signs
View Full Analysis

What is Tauns Laboratories Accounts Payable?

Tauns Laboratories TSE:197A 15 Accounts Payable is 円1,069 Mil as of Dec. 2025. GuruFocus rates TSE:197A with a GF Score™ of 15/100. The stock has 6 warning signs investors should review.

Tauns Laboratories's Accounts Payable for the quarter that ended in Dec. 2025 was 円1,069 Mil.

Tauns Laboratories's quarterly Accounts Payable increased from Jun. 2025 (円1,199 Mil) to Sep. 2025 (円1,298 Mil) but then declined from Sep. 2025 (円1,298 Mil) to Dec. 2025 (円1,069 Mil).

Tauns Laboratories's annual Accounts Payable increased from Jun. 2023 (円1,143 Mil) to Jun. 2024 (円1,483 Mil) but then declined from Jun. 2024 (円1,483 Mil) to Jun. 2025 (円1,199 Mil).

Tauns Laboratories Accounts Payable Related Terms

Tauns Laboratories Accounts Payable Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Accounts Payable Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25
Accounts Payable
1,390.89 1,143.42 1,482.76 1,199.04

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,296.99 1,199.04 1,298.14 1,068.58 631.84
TSE:197A
15GF Score
Tauns Laboratories Inc TSE:197A
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of 円1,069 Mil mean?
Tauns Laboratories (TSE:197A) has a Accounts Payable of 円1,069 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' Accounts Payable too high?
Tauns Laboratories' current Accounts Payable is 円1,069 Mil. Overall, Tauns Laboratories has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Accounts Payable compare to ISRG and BDX?
Tauns Laboratories' Accounts Payable of 円1,069 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Accounts Payable is 円1,069 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Accounts Payable of 円1,069 Mil. The current Accounts Payable is 円1,069 Mil. Tauns Laboratories' overall GF Score™ is 15/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Accounts Payable is 円1,069 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
15GF Score

Get the complete analysis for TSE:197A

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円468.00
Price